USFDA approves Biocon drug Pegfilgrastim from new Bengaluru facility
Biocon and its partner Mylan on November 27 said their supplemental Biologics License Application (sBLA) for Pegfilgrastim Drug Substance to...
Showing posts with label USFDA. Show all posts
Showing posts with label USFDA. Show all posts
Wednesday, November 27, 2019
Subscribe to:
Posts (Atom)
